ARTICLE | Clinical News
Taxotere docetaxel: Phase III data
August 22, 2005 7:00 AM UTC
In a U.S. and Canadian Phase III trial in 449 breast cancer patients comparing Taxotere to paclitaxel, Taxotere met the secondary endpoints of overall survival and time to progression. The median over...